BACKGROUND: Blood cultures (BCs) are used to diagnose bacteremia in febrile children. False-positive BCs increase costs because of further testing, longer hospital stays, and unnecessary antibiotic therapy. Data from a study at our hospital showed the emergency department consistently exceeded established guidelines of 2% to 4%. A phlebotomy policy change was made whereby BC had to be obtained by a second venipuncture and no longer obtained during insertion of intravenous catheters. METHODS: A descriptive study compared preintervention and postintervention blood culture contamination (BCC) rates. A BC was considered contaminated if a single culture grew coagulase-negative staphylococci, diphtheroids, Micrococcus spp, Bacillus spp, or viridans group streptococci. Patients with indwelling central lines or who grew pathogenic bacteria were excluded. RESULTS: Preintervention BCC was 120 (6.7% [SD, 2.3%]) of 1796. Postintervention BCC was 29 (2.3%, [SD, 0.8]) of 1229 with odds ratio of 2.96 (confidence interval, 1.96-4.57; P = 0.001). The most common contaminant was coagulase-negative staphylococcus, 21 (72%) of 120, followed by viridans streptococcus, 3 (10%) of 29, which was not significantly different between intervention periods. Before intervention, 44 patients were called back to the emergency department, and 25 were admitted because of BCC. After intervention, a total of 9 patients were called back, and 5 were admitted. The decrease in unnecessary hospitalization was statistically significant (P < 0.05). CONCLUSIONS: The new policy significantly reduced BCC rates, thereby decreasing unnecessary testing and hospitalizations. Coagulase-negative staphylococci and viridans streptococci remain the most common BC contaminants. Further research should focus on additional interventions to reduce BCC.
BACKGROUND: Blood cultures (BCs) are used to diagnose bacteremia in febrile children. False-positive BCs increase costs because of further testing, longer hospital stays, and unnecessary antibiotic therapy. Data from a study at our hospital showed the emergency department consistently exceeded established guidelines of 2% to 4%. A phlebotomy policy change was made whereby BC had to be obtained by a second venipuncture and no longer obtained during insertion of intravenous catheters. METHODS: A descriptive study compared preintervention and postintervention blood culture contamination (BCC) rates. A BC was considered contaminated if a single culture grew coagulase-negative staphylococci, diphtheroids, Micrococcus spp, Bacillus spp, or viridans group streptococci. Patients with indwelling central lines or who grew pathogenic bacteria were excluded. RESULTS: Preintervention BCC was 120 (6.7% [SD, 2.3%]) of 1796. Postintervention BCC was 29 (2.3%, [SD, 0.8]) of 1229 with odds ratio of 2.96 (confidence interval, 1.96-4.57; P = 0.001). The most common contaminant was coagulase-negative staphylococcus, 21 (72%) of 120, followed by viridans streptococcus, 3 (10%) of 29, which was not significantly different between intervention periods. Before intervention, 44 patients were called back to the emergency department, and 25 were admitted because of BCC. After intervention, a total of 9 patients were called back, and 5 were admitted. The decrease in unnecessary hospitalization was statistically significant (P < 0.05). CONCLUSIONS: The new policy significantly reduced BCC rates, thereby decreasing unnecessary testing and hospitalizations. Coagulase-negative staphylococci and viridans streptococci remain the most common BC contaminants. Further research should focus on additional interventions to reduce BCC.
Authors: Susan R Snyder; Alessandra M Favoretto; Rich Ann Baetz; James H Derzon; Bereneice M Madison; Diana Mass; Colleen S Shaw; Christopher D Layfield; Robert H Christenson; Edward B Liebow Journal: Clin Biochem Date: 2012-06-16 Impact factor: 3.281
Authors: Andrea T Cruz; Prashant Mahajan; Bema K Bonsu; Jonathan E Bennett; Deborah A Levine; Elizabeth R Alpern; Lise E Nigrovic; Shireen M Atabaki; Daniel M Cohen; John M VanBuren; Octavio Ramilo; Nathan Kuppermann Journal: JAMA Pediatr Date: 2017-11-06 Impact factor: 16.193
Authors: Russell J McCulloh; Michael P Koster; Dwight E Yin; Tiffany L Milner; Shawn L Ralston; Vanessa L Hill; Brian K Alverson; Eric A Biondi Journal: PLoS One Date: 2015-02-06 Impact factor: 3.240
Authors: Paul C Mullan; Sara Scott; James M Chamberlain; Jeanne Pettinichi; Katura Palacious; Anastasia Weber; Asha S Payne; Gia M Badolato; Kathleen Brown Journal: Pediatr Qual Saf Date: 2018-09-19
Authors: M Cervero; S Quevedo; M Del Álamo; P Del Valle; I Wilhelmi; R Torres; J L Agud; V Alcázar; S Vázquez; B García Journal: Rev Esp Quimioter Date: 2019-02-05 Impact factor: 1.553
Authors: Simon Leigh; Alison Grant; Nicola Murray; Brian Faragher; Henal Desai; Samantha Dolan; Naeema Cabdi; James B Murray; Yasmin Rejaei; Stephanie Stewart; Karl Edwardson; Jason Dean; Bimal Mehta; Shunmay Yeung; Frans Coenen; Louis W Niessen; Enitan D Carrol Journal: BMC Med Date: 2019-03-06 Impact factor: 8.775